Prescription Marijuana? FDA Rescheduling Memo Sets Stage To Test Whether There’s A Viable Market

Rise in state-legalized marijuana helped pushed FDA to recommend more lenient regulation of the substance, easing pathway to prescription drug approval, but those same state markets may pose a challenge for commercialization of an Rx botanical if DEA follows through on rescheduling.